Trials / Completed
CompletedNCT00772304
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To compare patient perceptions of the sensory attributes, including taste and aftertaste, of Olopatadine relative to azelastine when administered as a single dose in patients with allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olopatadine 0.6% / Azelastine 137 mcg | single dose; 2 sprays per nostril |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2008-11-01
- First posted
- 2008-10-15
- Last updated
- 2010-03-02
- Results posted
- 2010-02-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00772304. Inclusion in this directory is not an endorsement.